ORGESTRA - Organoid technologies for disease modelling, drug discovery and development for rare diseases

EU funded MSCA Joint Doctoral Network

Doctoral supervisor.

Biocompatible Coatings with Natural-Based Nano-Agents for Biomedical Applications

BioISI Internal Grant

Principal Investigators: Noelia Losada García & Hugo M. Botelho.

NewKinCF – Unraveling the mechanism of action of a novel kinase regulator of F508del-CFTR traffic and activity

FCT Exploratory Project

2022.03453.PTDC

Principal Investigator: Hugo M. Botelho.

VALHealth – Valorisation of Algae for Health: Bioactive Compounds from Marine Bioresources by Membrane Technology

BioISI Internal Grant

Principal Investigators: Rita Pacheco & Hugo M. Botelho.

Deconvolution of dual CFTR/ANO1 Modulators from Portuguese natural products - A new class of drugs for CF therapy

BioISI Internal Grant

Principal Invesigators: Helena Gaspar, Helena Vieira & Hugo M. Botelho.

A new class of drugs for CF therapy - Dual CFTR/ANO1 Modulators from Portuguese natural products

BioISI Internal Grant

Principal Invesigators: Helena Vieira & Hugo M. Botelho.

Natural compounds as a source of novel drug leads for Cystic Fibrosis

BioISI Internal Grant

Principal Invesigators: Helena Vieira & Hugo M. Botelho.

The identification of new natural compounds of high therapeutic potential for Cystic Fibrosis by high-throughput microscopy screens

BioISI Internal Post-Doc Recruitment Grant

Supervisors: Helena Vieira & Hugo M. Botelho.